Brief: Shield Therapeutics CEO Greg Madison Steps Down
24/07/2024 07:26
July 24 (Reuters) - Shield Therapeutics PLC STXS.L :
* SHIELD THERAPEUTICS PLC - GREG MADISON, CHIEF EXECUTIVE
OFFICER,
WILL BE STEPPING DOWN
* SHIELD THERAPEUTICS PLC - ANDERS LUNDSTROM APPOINTED
INTERIM
CHIEF EXECUTIVE OFFICER
Source text for Eikon: ID:nRSX5564Xa
Further company coverage: STXS.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shield Therapeutics
See all newsBrief: Shield Therapeutics To Assume Full Commercial Control Of ACCRUFeR In US
Shield Therapeutics - Shield assumes full control of ACCRUFeR® in the US
Shield Therapeutics - Interim results for the six months ended 30 Jun 26
Brief: Shield Therapeutics Says On Track For Profitability In 2026; Appoints Michael Jensen As CFO
Shield Therapeutics - Q2 and H1 2026 Trading Update